Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GSK | NYSE | USD | Real-time | |
GSKl | BATS Europe | GBP | Delayed | |
GLAXF | OTC Markets | USD | Delayed | |
GSK | London | GBP | Real-time | |
GSKN | Mexico | MXN | Delayed | |
GS71 | Xetra | EUR | Delayed | |
GS71 | TradeGate | EUR | Delayed | |
GS70y | Frankfurt | EUR | Delayed | |
GS71 | Frankfurt | EUR | Delayed | |
GSKm | Buenos Aires | ARS | Delayed |
Period Ending: | 2024 31/03 |
2023 31/12 |
2023 30/09 |
2023 30/06 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 7363 | 8052 | 8147 | 7178 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 1915 | 2815 | 2243 | 1899 | ||||||||||||||||||||||||||||||
Gross Profit | 5448 | 5237 | 5904 | 5279 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 5116 | 6413 | 5591 | 5127 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 2247 | 1639 | 2556 | 2051 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | -61 | - | - | ||||||||||||||||||||||||||||||
Other, Net | 892 | 1321 | 765 | 64 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 1355 | 379 | 1791 | 1987 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 274 | -19 | 257 | 242 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1081 | 398 | 1534 | 1745 | ||||||||||||||||||||||||||||||
Minority Interest | -611 | -552 | -514 | -532 | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1046 | 350 | 1464 | 1624 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 1046 | 350 | 1464 | 1624 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | 1046 | 350 | 1464 | 1624 | ||||||||||||||||||||||||||||||
Dilution Adjustment | 1.3 | -2.78 | 0.128 | -0.921 | ||||||||||||||||||||||||||||||
Diluted Net Income | 1044.7 | 352.78 | 1463.87 | 1624.92 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 4113 | 4116 | 4112 | 4093 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | 0.254 | 0.086 | 0.356 | 0.397 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | 0.15 | 0.16 | 0.14 | 0.14 | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.313 | 0.207 | 0.348 | 0.26 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review